Population
Cancer patients with a hypercoagulable state and thrombosis
Design
Review
Authors
Loading...
Should not change antithrombotic use in cancer; leaves open anti-metastatic effects for prospective trials.
Antithrombotic agents such as low molecular weight heparin and warfarin may inhibit angiogenesis and tumor metastasis in cancer patients beyond their anticoagulant effects.
Shaker A. Mousa (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: